Combined intervention of quarantine, school closure, workplace distancing projected to be most effective.
Low expression of the HPV-related marker cyclin D1 appears to be an independent prognostic marker in Barrett high-grade dysplasia and esophageal adenocarcinoma.
Dried blood spot viral load may be more accurate and useful than plasma viral load for patients with HIV in settings with limited resources.
The point-of-care Dual Path Platform (DPP®) assay may be an inexpensive tool for the diagnosis of neurosyphilis.
For patients suspected of having COVID-19, undergoing REMS-required testing to obtain a medication may put others at risk.
Women are less likely to be tested for HIV or offered prep at time of sexually transmitted infection diagnosis.
The FDA has issued an Emergency Use Authorization to Thermo Fisher for its TaqPath COVID-19 Combo Kit, a diagnostic test that detects nucleic acid from SARS-CoV-2, the virus that causes coronavirus disease 2019.
A study identifies risk factors for hepatocellular carcinoma (HCC) after the first 5 years of receiving antiviral therapy in white patients with chronic hepatitis B.
Vice President Mike Pence told reporters millions of much-needed testing kits for COVID-19 are on the way to clinics and labs nationwide.
A protein epitope targeted by the antibody response in children with Kawasaki disease has been identified.
The Centers for Disease Control and Prevention has updated the guidance for evaluation of persons under investigation for coronavirus disease 2019 (COVID-19), expanding the criteria to a wider group of symptomatic patients.
New evidence supports the possibility of gastrointestinal infection with the novel SARS-CoV-2 virus, as well as a possible feco-oral route of transmission.
Less than one-quarter of infants exposed to hepatitis C virus (HCV) receive testing.
Chest computed tomography has higher sensitivity for detecting 2019 novel COVID-19 than reverse-transcription polymerase chain reaction tests.
The USPSTF recommends screening for hepatitis C virus infection in all adults.
Communication between pediatricians and adolescent boys who engage in same-sex sexual intercourse may be a potential avenue to increase HIV testing.
Screening for HIV and hepatitis C virus in medical clinics or emergency departments is infrequent among patients with indicators for injection-drug use.
Infections with the 2019 novel coronavirus (2019-nCoV) was of clustering onset and more likely to affect older men with comorbid diseases.
Between 2010 and 2017, the use of an antibody-based HIV-1/HIV-2 differentiation test increased in the United States, but the number of confirmed HIV-2 diagnoses remained low.
Four POC tests for HIV that use unprocessed specimens are able to detect HIV infections with high specificity and sensitivity.